Trial Spotlight: Zofia Piotrowska on the EA5162 Trial for Patients with Advanced Non-Small Cell Lung Cancer
November 25, 2024Fall 2024 Group Meeting Focuses on Real-World Data, Innovation, and Health Equity
November 25, 202454 Member Networks and Programs Receive Commendations in 2024 for Research Performance
Each year, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) conducts an Institution Evaluation in which a subset of Principal Investigator (PI) Committee members and senior administrators meet to evaluate the performance of ECOG-ACRIN member networks and programs. The exceptional staff in the Membership Department facilitates the process—encompassing nearly 1500 individual research institutions in total, comprising 140 research programs. Through this annual review, principal investigators and research personnel stay informed about the many scientific and administrative components that comprise ECOG-ACRIN's expectations for retaining membership in the Group. In addition, the evaluation ensures that member institutions maintain ECOG-ACRIN's high standards for conducting cancer research with and through the Group.
Data from the previous calendar year (2023) was evaluated. The following areas are part of the review: accrual, clinical data quality and timeliness, compliance with requirements for submission of laboratory samples and images, scientific leadership, administrative contribution, and compliance with policies of both ECOG-ACRIN and the National Cancer Institute (NCI) through its National Clinical Trials Network (NCTN) audit process. The review committee is blinded to the identity of the institutions during this initial evaluation when they give a numerical rating to these categories. However, final unblinded assessments are based on objective data and discussions on the unique aspects of each institution that cannot be captured in a numerical rating.
For 2024, the review committee voted to commend the following 54 networks and NCI Community Oncology Research Programs (NCORPs). Group Co-Chairs Peter J. O'Dwyer, MD, and Mitchell D. Schnall, MD, PhD, recognized them during the Fall 2024 Group Meeting General Session.
Overall Outstanding Performance
Institution |
Principal Investigator |
Aultman Health System/Timken Family Cancer Center |
Sunitha Vemulapalli, MD |
Aurora NCORP |
Thomas J. Saphner, MD |
Carle Cancer Center NCORP |
Kendrith M. Rowland, MD |
Delaware/Christiana Care NCORP |
Gregory A. Masters, MD |
Duke University/Duke Cancer Institute |
Daniel P. Barboriak, MD |
Heartland Cancer Research NCORP |
Bryan A. Faller, MD |
Johns Hopkins University/The Sidney Kimmel Cancer Center |
Julie R. Brahmer, MD |
Mayo Clinic Cancer Center |
Thomas M. Habermann, MD |
Medical College of Wisconsin/MCW Cancer Center |
Timothy S. Fenske, MD |
Mount Sinai Health System/The Tisch Cancer Institute |
Joseph A. Sparano, MD |
New York University/NYU Langone Perlmutter Cancer Center |
Catherine S. Diefenbach, MD |
Northwestern University/Robert H. Lurie Comprehensive Cancer Center |
Al B. Benson III, MD |
The Ohio State University/The James Comprehensive Cancer Center |
James W. Rocco, MD PhD |
The University of Texas/MD Anderson Cancer Center |
In Transition |
University of Massachusetts/UMass Cancer Center |
Jan Cerny, MD, PhD |
University of North Carolina at Chapel Hill/UNC Lineberger Comprehensive Cancer Center |
Lisa A. Carey, MD |
University of Pennsylvania/Abramson Cancer Center |
Jennifer R. Eads, MD |
University of Washington/Fred Hutchinson Cancer Center |
Evan Y. Yu, MD |
Vanderbilt University/Vanderbilt-Ingram Cancer Center |
Kristen K. Ciombor, MD, MSCI |
Yale University/Yale Cancer Center |
Barbara A. Burtness, MD |
Accrual, Scientific Contribution, and Administrative Participation
Institution |
Principal Investigator |
University of South Florida/Moffitt Cancer Center |
Jhanelle E. Gray, MD |
Accrual, Scientific Contribution, and Imaging Submission
Institution |
Principal Investigator |
University of Wisconsin/UW Carbone Cancer Center |
Kari B. Wisinski, MD |
Accrual and Scientific Contribution
Institution |
Principal Investigator |
Emory University/Winship Cancer Institute |
Charles A. Staley III, MD |
Memorial Sloan Kettering Cancer Center |
In Transition |
Accrual and Data Management
Institution |
Principal Investigator |
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center |
Thomas A. Hope, MD |
Yonsei University Health System-Severance Hospital |
Joohyuk Sohn, MD |
Accrual
Institution |
Principal Investigator |
CERIM |
Daniel E. Lehrer, MD |
Gulf South Minority Underserved NCORP |
Augusto C. Ochoa, MD |
Hackensack University Medical Center |
Donna M. McNamara, MD |
Memorial Hermann Texas Medical Center |
Syed H. Jafri, MD |
National Cancer Center-Korea |
Ji-Youn Han, MD |
Allegheny General Hospital |
Nathan Bahary, MD, PhD |
Grupo de Estudios Clinicos Oncologicos del Peru |
Carlos S. Vallejos Sologuren, MD |
Scientific Contribution and Administrative Participation
Institution |
Principal Investigator |
Harvard University/Dana-Farber Cancer Center |
Frank S. Hodi, MD |
National Capital Area Minority Underserved NCORP |
Geoffrey T. Gibney, MD |
Wisconsin NCORP |
Kurt R. Oettel, MD |
Scientific Contribution
Institution |
Principal Investigator |
Case Western Reserve University/Case Comprehensive Cancer Center |
Paolo F. Caimi, MD |
Fox Chase Cancer Center |
Hossein Borghaei, DO |
Indiana University/IU Melvin and Bren Simon Comprehensive Cancer Center |
Kathy D. Miller, MD |
Montefiore Minority Underserved NCORP |
Balazs Halmos, MD |
Rutgers Cancer Institute of New Jersey |
Howard S. Hochster, MD |
Stanford University/Stanford Cancer Institute |
Melinda L. Telli, MD |
Thomas Jefferson University/Sidney Kimmel Comprehensive Cancer Center |
Steven J. Cohen, MD |
Tufts University/Tufts Medical Center Cancer Center |
Rachel J. Buchsbaum, MD |
University of Michigan/UM Comprehensive Cancer Center |
In Transition |
University of Pittsburgh/UPMC Hillman Cancer Center |
John M. Kirkwood, MD |
The University of Texas Southwestern/Harold C. Simmons Comprehensive Cancer Center |
David E. Gerber, MD |
Washington University at St. Louis/Siteman Cancer Center |
Barry A. Siegel, MD |
Data Management, Laboratory Submission, and Imaging Submission
Institution |
Principal Investigator |
Penn State University/Penn State Cancer Institute |
Cristina I. Truica, MD |
Data Management
Institution |
Principal Investigator |
Cancer Partners of Nebraska |
Joni A. Tilford, MD |
Essentia Health NCORP |
Bret E. Friday, MD, PhD |
Puerto Rico Minority Underserved NCORP |
Luis J. Santos Reyes, MD |
Upstate Carolina NCORP |
James D. Bearden III, MD |